ponatinib,imatinib,Vincristine,Dexamethasone,Cytarabine,Methotrexate,Prednisone
takeda,incyte,otsuka
['imatinib', 'ponatinib', 'ph+ all']
happening now at #eha23: bct associate editor elias jabbour, md, of is presenting the first report from the phase iii phallcon study of ponatinib versus imatinib in newly diagnosed ph+ all. 
Translating Hematologic Oncology Discoveries into Practice.